Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Rhabdomyosarcoma 1

Interventions

Cyclophosphamide 7X-Rays 5Vincristine 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Vinorelbine 4Specimen Handling 4Nuclear Medicine Department, Hospital 4Irinotecan 4Dactinomycin 4Biopsy 4Radiotherapy 3Radiation 3Etoposide 3ulixertinib 2tipifarnib 2selpercatinib 2palbociclib 2larotrectinib 2ivosidenib 2etoposide phosphate 2ensartinib 2Temozolomide 2Sirolimus 2Ifosfamide 2Filgrastim 2Doxorubicin 2Dexrazoxane 2temsirolimus 1tazemetostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Rhabdomyosarcoma × Vascular Endothelial Growth Factor A × Clear all
NCT01871766 2026-04-24

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
115 enrolled
Sarcoma

Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡